Order Article Reprints

Haggag YA, Matchett KB, Falconer RA, Isreb M, Jones J, Faheem A, McCarron P, El-Tanani M. Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo. Cancers. 2019; 11(2):222. https://doi.org/10.3390/cancers11020222

Haggag, Yusuf A., Kyle B. Matchett, Robert A. Falconer, Mohammad Isreb, Jason Jones, Ahmed Faheem, Paul McCarron, and Mohamed El-Tanani. 2019. "Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo" Cancers 11, no. 2: 222. https://doi.org/10.3390/cancers11020222

Haggag, Y. A., Matchett, K. B., Falconer, R. A., Isreb, M., Jones, J., Faheem, A., McCarron, P., & El-Tanani, M. (2019). Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo. Cancers, 11(2), 222. https://doi.org/10.3390/cancers11020222